Seeing Is Believing

Currently out of the existing stock ratings of Boris Peaker, 22 are a HOLD (38.6%), 35 are a BUY (61.4%).
Analyst Boris Peaker, currently employed at TD COWEN, carries an average stock price target met ratio of 64.3% that have a potential upside of 37.9% achieved within 140 days.
Boris Peaker’s has documented 104 price targets and ratings displayed on 20 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on HRTX, Heron Therapeuti at 14-Nov-2023.
Analyst best performing recommendations are on CTIC (CTI BIOPHARMA CORP).
The best stock recommendation documented was for CTIC (CTI BIOPHARMA CORP) at 4/17/2023. The price target of $8 was fulfilled within 23 days with a profit of $3.6 (81.82%) receiving and performance score of 35.57.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy
$48
$21.28 (79.64%)
$3
10 days ago
(20-Oct-2025)
1/5 (20%)
$20.09 (71.98%)
248
Buy
$62
$35.28 (132.04%)
$62
1 months 14 days ago
(16-Sep-2025)
0/3 (0%)
$37.54 (153.48%)
Buy
$42
$15.28 (57.19%)
$50
2 months 11 days ago
(19-Aug-2025)
6/30 (20%)
$21.11 (101.05%)
256
Buy
$38
$11.28 (42.22%)
$37
2 months 11 days ago
(19-Aug-2025)
4/5 (80%)
$17.11 (81.91%)
165
Buy
$48
$21.28 (79.64%)
$70
2 months 11 days ago
(19-Aug-2025)
0/2 (0%)
$27.11 (129.78%)
What Year was the first public recommendation made by Boris Peaker?